Semantic Scholar uses AI to extract papers important to this topic.
ORM‐12741 is a novel selective antagonist of alpha‐2C adrenoceptors. This trial evaluated the safety and efficacy of ORM‐12741 in… Expand Treatment of TBI remains a major unmet medical need, with 2.5 million new cases of traumatic brain injury (TBI) each year in… Expand OBJECTIVES
Our primary purpose was to evaluate the efficacy of the high-potency α2C-adrenoceptor antagonist ORM-12741 in the… Expand Objectives. Our primary purpose was to evaluate the efficacy of the high-potency a2C-adrenoceptor antagonist ORM-12741 in the… Expand WCN 2013 No: 1048 Topic: 5 — Dementia Dementia diagnoses in the young are based on inadequate diagnostic evaluations — A… Expand